Treatment with the PPARγ antagonist GW9662 was found to decrease the growth of PC3 xenografts in an orthotopic mouse model, but this decrease did not reach statistical significance.
← all excerpts
The role of peroxisome proliferator-activated receptor gamma in prostate cancer.
1
—
—